Analysis of Hospital Expenses and Influencing Factors of Cerebral Infarction Sequelae Patients with Dominant Diseases of TCM
- VernacularTitle:中医优势病种脑梗死后遗症患者住院费用及影响因素分析
- Author:
Sa DU
1
;
Zhiwu GUO
;
Jian LIU
Author Information
1. 广州中医药大学第四临床医学院 广东 深圳 518033
- Keywords:
advantageous diseases of traditional Chinese medicine;
cerebral infarction;
hospitalization cost;
influencing factor
- From:
Chinese Health Economics
2024;43(3):29-32
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To study the composition and influencing factors of hospitalization expenses of patients with sequelae of ce-rebral infarction caused by the dominant diseases of traditional Chinese medicine(TCM),so as to provide references for the fine management within the hospital and the medical insurance department to improve the payment policy suitable for the characteristics of TCM.Method:A total of 1 261 cases with ICD code 169.3 in the sample of tertiary traditional Chinese medicine hospitals from 2020 to 2022 were collected.Single factor analysis,correlation analysis,multiple linear stepwise regression and other methods were used to analyze the composition and main influencing factors of hospitalization expenses of patients with cerebral infarction sequelae.Re-sults:The average length of hospital stay of patients with sequelae of cerebral infarction was 16.71 days per time,the average hospi-talization cost was 24 148.83 yuan per time,and the proportion of TCM treatment cost per time was 54.43％.The results of stepwise regression showed that the length of stay,the condition of admission and the complication of pulmonary infection had a significant im-pact on the hospitalization expenses(P＜0.05),and the length of stay had the greatest impact.Conclusion:It is suggested that the hospital should optimize and improve the clinical pathway of TCM dominant diseases and establish an effective dynamic management mechanism,and the medical insurance department should improve the adjustment mechanism of the auxiliary list of TCM dominant diseases under the disease scoring payment.
